◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › BLLN

BillionToOne, Inc. (BLLN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-07-15

BillionToOne, Inc. (BLLN) operates in the Diagnostics & Research industry and is headquartered in Menlo Park, United States with about 713 employees. Its market capitalization is roughly $6 billion. In the fiscal year ended 2025-12-31, BLLN reported $305M in revenue and $8M in net income.

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.

Interactive charts & full statements → Open the BLLN valuation workbench →

BLLN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue$305M
Gross Profit$208M
Operating Income (EBIT)$16M
Net Income$8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLLN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$108M$96M$84M$67M$59M
Gross Profit$79M$69M$58M$44M$38M
Operating Income (EBIT)$18M$10M$10M($2M)($2M)
Net Income$18M$6M$6M($0M)($4M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLLN Free Cash Flow History

BLLN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-31
Total Assets$633M
Total Liabilities$152M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLLN viewer.

Other Companies in Diagnostics & Research

← BLKBAll stocksBLMN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.